Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

BACKGROUND: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Iran J Public Health
Egile Nagusiak: FATHI MAROUFI, Nazila, GHORBANIHAGHJO, Amir, SAYYAH MELLI, Manizheh, VAEZI, Maryam, HEKMATI AZAR MEHRABANI, Zohreh, BANNAZADEH AMIRKHIZ, Maryam, RASHTCHIZADEH, Nadereh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Tehran University of Medical Sciences 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439041/
https://ncbi.nlm.nih.gov/pubmed/28540268
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak